14 results
DEFR14A
ARCT
Arcturus Therapeutics Holdings Inc
12 May 22
Revised proxy
5:00pm
, dedication to human capital management is a core component of our corporate governance and culture. Our comprehensive approach to human capital management
8-K
EX-14.1
tb0vcn
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
10-K
v4czsiwjhswl0 z1fe7
16 Mar 20
Annual report
11:09am
8-K
EX-99.1
j6l3ogc667edr7erzoeq
4 Mar 20
Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR TechnologyTM
8:52am
DEF 14A
1lxcvsd mzmiwwtt2gd
1 Oct 19
Definitive proxy
6:07am
8-K12B
xma4a
14 Jun 19
Notification of registration of securities
5:10pm
424B3
rh3ewcq6 nxa2mxaqy7
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
0btae 3zi
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
1c4gfye
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next